ASRGL1 Protein
(1 reference)-
- Target See all ASRGL1 Proteins
- ASRGL1 (Asparaginase Like 1 (ASRGL1))
- Reactivity
- Please inquire
- Host
- Please inquire
- Characteristics
- L-Asparaginase
- Purity
- > 96.0 % as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.
- Top Product
- Discover our top product ASRGL1 Protein
-
Asparaginase Like 1 (ASRGL1) (AA 1-308) protein (His tag)
ASRGL1 Origin: Human Host: Escherichia coli (E. coli) Recombinant Greater than 95 % as determined by SDS-PAGE ELISA, WB
Asparaginase Like 1 (ASRGL1) (AA 1-180) protein (GST tag)ASRGL1 Origin: Human Host: Wheat germ Recombinant ELISA, WB, AA, AP
Asparaginase Like 1 (ASRGL1) (Transcript Variant 2) protein (Myc-DYKDDDDK Tag)ASRGL1 Origin: Human Host: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
Asparaginase Like 1 (ASRGL1) (Transcript Variant 1) protein (Myc-DYKDDDDK Tag)ASRGL1 Origin: Human Host: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- The enzyme was lyophilized with no additives.
- Storage
- -20 °C
-
-
: "Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner." in: Apoptosis : an international journal on programmed cell death, Vol. 19, Issue 11, pp. 1616-26, (2014) (PubMed).
-
: "Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner." in: Apoptosis : an international journal on programmed cell death, Vol. 19, Issue 11, pp. 1616-26, (2014) (PubMed).
-
- Target
- ASRGL1 (Asparaginase Like 1 (ASRGL1))
- Alternative Name
- L-Asparaginase (ASRGL1 Products)
- Background
- L-Asparaginase produced from E.Coli containing 303 amino acids and having a molecular mass of 31731 Dalton. Introduction: L-Asparaginase is an enzyme that depletes L-Asparagine ,an important nutrient for cancer cells, resulting in cancer/tumor cell starvation. L-asparaginase is an anti-tumor agent derived from E.coli.,which can inhibit the growth of malignant cells. It is used mainly for the induction of remission in acute lymphoblastic leukaemia. Because of the lymph node origin of malignant B cells in Multiple Myeloma, L-Asparagine is an essential amino acid for their cell metabolism, and, consequently, L-Asparaginase may be of value in managing the disease. The rationale behind asparaginase is that it takes advantage of the fact that ALL cellsare unable to synthesize the non-essential amino acidasparaginewhereas normal cells are able to make their own asparagine. These leukemic cells depend on circulating asparagine. Asparaginase however catalyzes the conversion of L-asparagine to aspartic acidand ammonia. This deprives the leukemic cell of circulating asparagine.
-
